• phone 1-855-475-7782 | fax 1-855-475-7787

global pharmacy plus review

shop secure


DUAKLIR GENUAIR (aclidinium bromide/formoterol) 400mcg/12mcg, 60 Dose

Product Details

Duaklir® is a fixed dose combination product recently approved in the United States as a treatment for COPD. It contains the long-acting muscarinic antagonist aclidinium bromide and the long-acting beta agonist formoterol fumarate. Duaklir® is presented as a dry powder for inhalation and is delivered via the breath-actuated multi-dose inhaler Pressair®.

DUAKLIR PRESSAIR is a combination of aclidinium bromide (an anticholinergic) and formoterol fumarate (a LABA) indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

International versions of this inhaler may have a label strength of 340mcg/12mcg (corresponds to a metered dose of 400mcg/12mcg). These products supply the same amount of active ingredient as the corresponding US brand product, the difference is due to alternate EU ways of measuring the strength.

Each delivered dose (leaving the mouthpiece) contains 396 mcg of aclidinium bromide (equivalent to 340 mcg of aclidinium) and 11.8 mcg of formoterol fumarate dihydrate. This corresponds to a metered dose of 400/12mcg aclidinium/formoterol.

Availability: In stock


There are no products matching the selection.

120.00 In stock